Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity

Retroviruses package their full-length, dimeric genomic RNA (gRNA) via specific interactions between the Gag polyprotein and a “Ψ” packaging signal located in the gRNA 5′-UTR. Rous sarcoma virus (RSV) gRNA has a contiguous, well-defined Ψ element, that directs the packaging of heterologous RNAs effi...

Full description

Bibliographic Details
Main Authors: Shuohui Liu, Rebecca Kaddis Maldonado, Tiffiny Rye-McCurdy, Christiana Binkley, Aissatou Bah, Eunice C. Chen, Breanna L. Rice, Leslie J. Parent, Karin Musier-Forsyth
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/5/568
_version_ 1797567293590339584
author Shuohui Liu
Rebecca Kaddis Maldonado
Tiffiny Rye-McCurdy
Christiana Binkley
Aissatou Bah
Eunice C. Chen
Breanna L. Rice
Leslie J. Parent
Karin Musier-Forsyth
author_facet Shuohui Liu
Rebecca Kaddis Maldonado
Tiffiny Rye-McCurdy
Christiana Binkley
Aissatou Bah
Eunice C. Chen
Breanna L. Rice
Leslie J. Parent
Karin Musier-Forsyth
author_sort Shuohui Liu
collection DOAJ
description Retroviruses package their full-length, dimeric genomic RNA (gRNA) via specific interactions between the Gag polyprotein and a “Ψ” packaging signal located in the gRNA 5′-UTR. Rous sarcoma virus (RSV) gRNA has a contiguous, well-defined Ψ element, that directs the packaging of heterologous RNAs efficiently. The simplicity of RSV Ψ makes it an informative model to examine the mechanism of retroviral gRNA packaging, which is incompletely understood. Little is known about the structure of dimerization initiation sites or specific Gag interaction sites of RSV gRNA. Using selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE), we probed the secondary structure of the entire RSV 5′-leader RNA for the first time. We identified a putative bipartite dimerization initiation signal (DIS), and mutation of both sites was required to significantly reduce dimerization in vitro. These mutations failed to reduce viral replication, suggesting that in vitro dimerization results do not strictly correlate with in vivo infectivity, possibly due to additional RNA interactions that maintain the dimers in cells. UV crosslinking-coupled SHAPE (XL-SHAPE) was next used to determine Gag-induced RNA conformational changes, revealing G218 as a critical Gag contact site. Overall, our results suggest that disruption of either of the DIS sequences does not reduce virus replication and reveal specific sites of Gag–RNA interactions.
first_indexed 2024-03-10T19:39:43Z
format Article
id doaj.art-6aa298b580df42dcb1f56745c37972bd
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T19:39:43Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-6aa298b580df42dcb1f56745c37972bd2023-11-20T01:22:04ZengMDPI AGViruses1999-49152020-05-0112556810.3390/v12050568Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral InfectivityShuohui Liu0Rebecca Kaddis Maldonado1Tiffiny Rye-McCurdy2Christiana Binkley3Aissatou Bah4Eunice C. Chen5Breanna L. Rice6Leslie J. Parent7Karin Musier-Forsyth8Department of Chemistry and Biochemistry, Center for Retroviral Research, and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USADepartments of Medicine, Division of Infectious Diseases and Epidemiology, Penn State College of Medicine, Hershey, PA 17033, USADepartment of Chemistry and Biochemistry, Center for Retroviral Research, and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USADepartment of Chemistry and Biochemistry, Center for Retroviral Research, and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USADepartment of Chemistry and Biochemistry, Center for Retroviral Research, and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USADepartments of Medicine, Division of Infectious Diseases and Epidemiology, Penn State College of Medicine, Hershey, PA 17033, USADepartments of Medicine, Division of Infectious Diseases and Epidemiology, Penn State College of Medicine, Hershey, PA 17033, USADepartments of Medicine, Division of Infectious Diseases and Epidemiology, Penn State College of Medicine, Hershey, PA 17033, USADepartment of Chemistry and Biochemistry, Center for Retroviral Research, and Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USARetroviruses package their full-length, dimeric genomic RNA (gRNA) via specific interactions between the Gag polyprotein and a “Ψ” packaging signal located in the gRNA 5′-UTR. Rous sarcoma virus (RSV) gRNA has a contiguous, well-defined Ψ element, that directs the packaging of heterologous RNAs efficiently. The simplicity of RSV Ψ makes it an informative model to examine the mechanism of retroviral gRNA packaging, which is incompletely understood. Little is known about the structure of dimerization initiation sites or specific Gag interaction sites of RSV gRNA. Using selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE), we probed the secondary structure of the entire RSV 5′-leader RNA for the first time. We identified a putative bipartite dimerization initiation signal (DIS), and mutation of both sites was required to significantly reduce dimerization in vitro. These mutations failed to reduce viral replication, suggesting that in vitro dimerization results do not strictly correlate with in vivo infectivity, possibly due to additional RNA interactions that maintain the dimers in cells. UV crosslinking-coupled SHAPE (XL-SHAPE) was next used to determine Gag-induced RNA conformational changes, revealing G218 as a critical Gag contact site. Overall, our results suggest that disruption of either of the DIS sequences does not reduce virus replication and reveal specific sites of Gag–RNA interactions.https://www.mdpi.com/1999-4915/12/5/568Rous sarcoma virus (RSV)retrovirusesGag polyproteinpackaging signal (Ψ)selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE)RNA secondary structure
spellingShingle Shuohui Liu
Rebecca Kaddis Maldonado
Tiffiny Rye-McCurdy
Christiana Binkley
Aissatou Bah
Eunice C. Chen
Breanna L. Rice
Leslie J. Parent
Karin Musier-Forsyth
Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity
Viruses
Rous sarcoma virus (RSV)
retroviruses
Gag polyprotein
packaging signal (Ψ)
selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE)
RNA secondary structure
title Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity
title_full Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity
title_fullStr Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity
title_full_unstemmed Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity
title_short Rous Sarcoma Virus Genomic RNA Dimerization Capability In Vitro Is Not a Prerequisite for Viral Infectivity
title_sort rous sarcoma virus genomic rna dimerization capability in vitro is not a prerequisite for viral infectivity
topic Rous sarcoma virus (RSV)
retroviruses
Gag polyprotein
packaging signal (Ψ)
selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE)
RNA secondary structure
url https://www.mdpi.com/1999-4915/12/5/568
work_keys_str_mv AT shuohuiliu roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT rebeccakaddismaldonado roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT tiffinyryemccurdy roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT christianabinkley roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT aissatoubah roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT eunicecchen roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT breannalrice roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT lesliejparent roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity
AT karinmusierforsyth roussarcomavirusgenomicrnadimerizationcapabilityinvitroisnotaprerequisiteforviralinfectivity